In this CME activity, Review the latest advancements in human epidermal growth factor receptor 2 (HER2)-ultralow mBC by joining this in-depth discussion between leading pathology and medical oncology experts. Learn how a new drug indication as well as updated ASCO/CAP guidelines for HER2-low and -ultralow classifications will redefine the way patients with HER2 mBC are…
Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions…
The future of radiation therapy is upon us, with game-changing advancements in adaptive radiation therapy, AI-powered treatment planning, biomarker-guided radiation delivery and precision imaging. These innovations will allow us to deliver more targeted treatments, reducing side effects while maximizing efficacy—ultimately enhancing patient quality of life. Join us on this exciting journey as we redefine the…
